Tofflon Science and Technology Group Co., Ltd. (SHE:300171)

China flag China · Delayed Price · Currency is CNY
15.75
-0.73 (-4.43%)
At close: Mar 9, 2026
15.81%
Market Cap 11.98B
Revenue (ttm) 5.22B
Net Income (ttm) 172.92M
Shares Out 760.85M
EPS (ttm) 0.23
PE Ratio 67.88
Forward PE 105.00
Dividend 0.06 (0.36%)
Ex-Dividend Date Sep 25, 2025
Volume 13,486,300
Average Volume 9,278,106
Open 16.29
Previous Close 16.48
Day's Range 15.40 - 16.30
52-Week Range 10.60 - 20.37
Beta 0.40
RSI 44.72
Earnings Date Apr 29, 2026

About SHE:300171

Tofflon Science and Technology Group Co., Ltd. engages in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. It operates through four segments: Biotechnology, Preparation Equipment, Engineering, and Food Engineering. The company offers technological research, such as cell technology, complex preparation, injection, and OSD laboratory; instruments, including cell therapy and nucleic acid drugs instruments, and table reactor; cryopreservation system for seeds and biological samples... [Read more]

Sector Healthcare
Founded 1993
Employees 5,417
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300171
Full Company Profile

Financial Performance

In 2024, SHE:300171's revenue was 5.01 billion, a decrease of -11.19% compared to the previous year's 5.64 billion. Earnings were 194.09 million, a decrease of -67.66%.

Financial Statements

News

There is no news available yet.